Latest RVNC reports update at 2024-05-09: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Revance Therapeutics
  4. Financial Ratios
  5. P/S Ratio
Revance Therapeutics logo
Revance Therapeutics RVNC
$ 4.29 0.47%
mail-toReport an Error

Revance Therapeutics P/S Ratio 2011-2024 | RVNC

Annual P/S Ratio Revance Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
2.05 19 11.6 96.3 2.35 K 171 3.92 K 1.8 K 1.68 K 815 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.92 K 2.05 1.09 K